Vorinostat

Nat Rev Drug Discov. 2007 Jan;6(1):21-2. doi: 10.1038/nrd2227.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Clinical Trials, Phase I as Topic
  • Drug Approval
  • Drug Design
  • Enzyme Inhibitors / pharmacology
  • Histone Deacetylase Inhibitors
  • Humans
  • Hydroxamic Acids / pharmacology
  • Hydroxamic Acids / therapeutic use*
  • Lymphoma, T-Cell, Cutaneous / drug therapy*
  • Skin Neoplasms / drug therapy*
  • United States
  • United States Food and Drug Administration
  • Vorinostat

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Vorinostat